Publicaciones en colaboración con investigadores/as de University of Birmingham (15)

2025

  1. Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults

    Transplantation Direct, Vol. 11, Núm. 5, pp. e1787

2024

  1. Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 859-883

2023

  1. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 8-15

  2. Contribution of Low CD4 Cell Counts and High Human Immunodeficiency Virus (HIV) Viral Load to the Efficacy of Preferred First-Line Antiretroviral Regimens for Treating HIV Infection: A Systematic Review and Meta-Analysis

    Clinical Infectious Diseases, Vol. 76, Núm. 11, pp. 2027-2037

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2022

  1. Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis

    Human reproduction update, Vol. 28, Núm. 4, pp. 501-517

2021

  1. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

    Internal and Emergency Medicine, Vol. 16, Núm. 3, pp. 591-599

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. ESC core curriculum for the cardiologist

    European Heart Journal, Vol. 41, Núm. 38, pp. 3605-3692

2019

  1. Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure

    Journal of the American College of Cardiology, Vol. 74, Núm. 23, pp. 2893-2904

2018

  1. Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: An individual patient-level analysis of double-blind randomized trials

    European Heart Journal, Vol. 39, Núm. 1, pp. 26-35

  2. Patient screening for early detection of aortic stenosis (AS) - Review of current practice and future perspectives

    Journal of Thoracic Disease, Vol. 10, Núm. 9, pp. 5584-5594

  3. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy

    Archives of Cardiovascular Diseases, Vol. 111, Núm. 2, pp. 74-84

  4. State of play and future direction with NOACs: An expert consensus

    Vascular Pharmacology, Vol. 106, pp. 9-21